Literature DB >> 26278648

Uveal Melanoma UK National Guidelines.

P Nathan1, V Cohen2, S Coupland3, K Curtis4, B Damato5, J Evans5, S Fenwick6, L Kirkpatrick7, O Li8, E Marshall9, K McGuirk4, C Ottensmeier10, N Pearce11, S Salvi12, B Stedman13, P Szlosarek14, N Turnbull15.   

Abstract

The United Kingdom (UK) uveal melanoma guideline development group used an evidence based systematic approach (Scottish Intercollegiate Guidelines Network (SIGN)) to make recommendations in key areas of uncertainty in the field including: the use and effectiveness of new technologies for prognostication, the appropriate pathway for the surveillance of patients following treatment for primary uveal melanoma, the use and effectiveness of new technologies in the treatment of hepatic recurrence and the use of systemic treatments. The guidelines were sent for international peer review and have been accredited by NICE. A summary of key recommendations is presented. The full documents are available on the Melanoma Focus website.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Choroidal; Guidelines; Melanoma; UK; Uveal

Mesh:

Year:  2015        PMID: 26278648     DOI: 10.1016/j.ejca.2015.07.013

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  25 in total

1.  Prognostic significance of PD-1/PD-L1 expression in uveal melanoma: correlation with tumor-infiltrating lymphocytes and clinicopathological parameters.

Authors:  Lata Singh; Mithalesh Kumar Singh; Maria Cristina Kenney; Martine J Jager; Moshahid Alam Rizvi; Rachna Meel; Neiwete Lomi; Sameer Bakhshi; Seema Sen; Seema Kashyap
Journal:  Cancer Immunol Immunother       Date:  2020-11-02       Impact factor: 6.968

2.  Surgery vs. radiotherapy in patients with uveal melanoma : Analysis of the SEER database using propensity score matching and weighting.

Authors:  Bum-Sup Jang; Ji Hyun Chang; Sohee Oh; Yu Jin Lim; Il Han Kim
Journal:  Strahlenther Onkol       Date:  2017-09-06       Impact factor: 3.621

Review 3.  Consensus statement for metastatic surveillance of uveal melanoma in Scotland.

Authors:  Vikas Chadha; Paul Cauchi; Wilma Kincaid; Ashita Waterston; Stefano Schipani; Sachin Salvi; Oliver Cram; Diana Ritchie
Journal:  Eye (Lond)       Date:  2022-08-09       Impact factor: 4.456

4.  Integrated analysis reveals the dysfunction of signaling pathways in uveal melanoma.

Authors:  Boxia Guo; Liang Xu; Songlin Sun; Rui Shi
Journal:  BMC Cancer       Date:  2022-07-05       Impact factor: 4.638

Review 5.  Recent Advances and Challenges in Uveal Melanoma Immunotherapy.

Authors:  Yihang Fu; Wei Xiao; Yuxiang Mao
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

6.  The Patient's Experience of Ocular Melanoma in the US: A Survey of the Ocular Melanoma Foundation.

Authors:  Armin R Afshar; Michael Deiner; Grant Allen; Bertil E Damato
Journal:  Ocul Oncol Pathol       Date:  2018-02-08

7.  Minimal contribution of ERK1/2-MAPK signalling towards the maintenance of oncogenic GNAQQ209P-driven uveal melanomas in zebrafish.

Authors:  Mai Abdel Mouti; Christopher Dee; Sarah E Coupland; Adam F L Hurlstone
Journal:  Oncotarget       Date:  2016-06-28

Review 8.  The biology of uveal melanoma.

Authors:  Adriana Amaro; Rosaria Gangemi; Francesca Piaggio; Giovanna Angelini; Gaia Barisione; Silvano Ferrini; Ulrich Pfeffer
Journal:  Cancer Metastasis Rev       Date:  2017-03       Impact factor: 9.264

9.  Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease.

Authors:  Ioannis Karydis; Alexandra Gangi; Matthew J Wheater; Junsung Choi; Iain Wilson; Kerry Thomas; Neil Pearce; Arjun Takhar; Sanjay Gupta; Danielle Hardman; Sean Sileno; Brian Stedman; Jonathan S Zager; Christian Ottensmeier
Journal:  J Surg Oncol       Date:  2017-12-28       Impact factor: 3.454

Review 10.  The genetics of uveal melanoma: current insights.

Authors:  Hildur Helgadottir; Veronica Höiom
Journal:  Appl Clin Genet       Date:  2016-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.